-
Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals
03 Jan 2025 00:41 GMT
… retreated from gene therapy, although it sells a hemophilia B gene therapy called Beqvez … acquired rights to similar, experimental lung cancer drugs in separate deals with … being evaluated against small-cell lung cancer, a more aggressive and less …
-
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer
17 Dec 2024 11:24 GMT
… trial of Reqorsa® Gene Therapy (quaratusugene ozeplasmid) … its pipeline of gene therapies in order to … product candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), is … gene-therapy-in-combination-with-tecentriq-in-extensive-stage-small-cell-lung-cancer …
-
Small cell lung cancer: Navigating the global clinical trial landscape
16 Dec 2024 15:20 GMT
… all lung cancer cases globally. Small cell lung cancer is … Globally, small cell lung cancer continues to pose a … cell lung cancer treatment.
Advancements in small cell lung cancer treatment … Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, …
-
Analysis of the Effects of Bevacizumab Combined with Chemoradiotherapy on VEGF, bFGF, and Let-7 Levels in Non-Small Cell Lung Cancer and the Factors Influencing Therapeutic Efficacy: A Retrospective Cohort Study
02 Dec 2024 18:59 GMT
… subtypes, non-small cell lung cancer (NSCLC) predominates, … lung cancer and induce cell cycle arrest of lung cancer … JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, … angiogenesis and anti-angiogenic gene therapy for cancer. Oncol Lett …
-
Genprex links with University of Michigan on lung cancer treatment
21 Nov 2024 17:59 GMT
… anaplastic lymphoma kinase] lung cancer research initiative researchers … position.”
Reqorsa gene therapy is currently undergoing … small-cell lung cancer (SCLC). Both lung cancer clinical … diabetes gene therapy approach.
Cell & Gene Therapy coverage …
-
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
21 Nov 2024 09:04 GMT
… drug candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), … Gene Therapy
REQORSA (quaratusugene ozeplasmid) for NSCLC and small-cell lung cancer … its pipeline of gene therapies in order … candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), …
-
Cell and Gene Therapies: The Global Race to Cure Everything—Pioneering the Next Frontier in Medicine!
19 Nov 2024 05:20 GMT
… CGT sector.
Cell and gene therapy (CGT) is at … , "Cell and Gene Therapies – Global Clinical Trial Landscape … , with gastrointestinal and lung cancers being areas of heightened … . Beyond hematologic malignancies, gene therapies are being explored for …
-
Global Cell and Gene Therapy Trials: Driving Innovation in Oncology and Beyond
14 Nov 2024 13:29 GMT
… attention on gastrointestinal tract and lung cancers, as well as hematological … are transforming the cell and gene therapy landscape, improving manufacturing efficiency and … significant potential of cell and gene therapies, particularly in oncology, and …
-
Watch: Three-drug treatment for lung cancer ‘shows encouraging progress’
08 Nov 2024 07:04 GMT
… three-drug treatment for lung cancer that could significantly … which are used in gene therapy to target and modify … of proteins responsible for lung cancer.
Scientists talk about the … manage lung cancer since 2016.
Video: Chris Sant Fournier
Lung cancer third …
-
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine’s Center for Cell and Gene Therapy
07 Nov 2024 14:42 GMT
… BCM) Center for Cell and Gene Therapy Institute (CAGT).
Dr. Ann … for pancreatic, breast, and lung cancer tissues before expanding to other … forefront of Cell and Gene Therapy innovation and played a … -center-for-cell-and-gene-therapy-302297587.html
SOURCE Bio- …